A CDC image of the novel coronavirus (COVID-10) SCAI and CAIC have created a registry to investigate the cardiovascular impact of the virus.
April 3, 2020 — The Society for Cardiovascular Angiography and Interventions (SCAI) and the Canadian Association of Interventional Cardiology (CAIC) announced the formation of the North American COVID-19 ST-Segment Elevation Myocardial Infarction Registry (NACMI). This will record data on novel coronavirus (COVID-19, SARS-CoV-2) patients who have STEMI. The purpose of the trial is to quickly gather information to understand the adverse cardiovascular effects being seen in COVID-19 patients.
"We believe that this registry has the potential to provide critically important time-sensitive data to inform the management and treatment guidelines applicable to COVID-19 patients," SCAI said in a statement on the study.
Any COVID-19 positive patients or persons under investigation (PUI) with ST-segment elevation or new-onset left bundle branch block (LBBB) with a clinical correlate of myocardial ischemia (including chest pain, dyspnea, cardiac arrest, hemodynamic instability) will be in enrolled. The data will be compared to an age and gender-matched control population from the existing Midwest STEMI Consortium, which is a large (>15,000), prospective multi-center registry of consecutive STEMI patients.
The study will be chaired by Tim Henry, M.D. from SCAI, Lindner Family Distinguished Chair in Clinical Research and medical drector of The Carl and Edyth Lindner Center for Research at The Christ Hospital, and Payam Dehghani, M.D., from CAIC, interventional cardiologist at Prairie Vascular Research Network in Regina, Canada. The NACMI registry has pending U.S. FDA Institutional Review Boards (IRB) approval and will have an ECG and angiographic core lab.
Interested sites can designate a local principal investigator and contact either SCAI PI Tim Henry ([email protected]), CAIC PI Payam Dehghani ([email protected]) or the data coordinating center ([email protected] or [email protected]) to obtain participating site information.
UPDATE Oct 14, 2020 - COVID-19 Positive STEMI Patients Have Higher Mortality , first data presented at TCT 2020 virtual meeting.